Lenders moot Eu1bn loan for Ratiopharm auction
Bankers are in early stages discussions over a potential financing of Eu900m-Eu1bn for the acquisition of Ratiopharm, the German generic pharmaceuticals company.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
